Cetuximab 205923-56-4

Cetuximab

询价 100mg 起订

500mg 起订

1000mg 起订

上海更新日期：2025-11-11

上海拓普韦尔生物医药科技有限公司

非会员

联系人：胡博

手机：13321917662 拨打

邮箱：sales@topwellpharma.com

产品详情:

中文名称：: 西妥昔单抗

英文名称：: Cetuximab

CAS号：: 205923-56-4

品牌：: Topwell

产地：: 上海市

纯度规格：: 98% SEC-HPLC

产品类别：: 生物类似抗体

靶点：: EGF receptor

生物作用：: Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR.

应用：: Cetuximab has potent antitumor activity.

Product Name:Cetuximab(C225),Stock solution

CAS:205923-56-4

Formula:C6484H10042N1732O2023S36

MW: 145781.6; 145.781 KD

Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity.

For research use only

Cetuximab;205923-56-4;

Shanghai Topwell Pharma Co., Ltd. is specialized in research, development, custom manufacturing and sales of APIs, Pharmaceutical Excipients, Health & Nutritional Ingredients, Polypeptides and Antibodies, etc.. Topwell has a professional R&D team. We have built close cooperative relationships with many research institutes and universities in China. In addition, we have very close cooperation relationships with many Chinese pharmaceutical factories. Topwell aims to become a global leader in pharmaceutical & chemical industry. 上海拓普韦尔生物医药科技有限公司专注于小分子药物发现领域的分子砌块和工具化合物的研究开发，为全球医药企业和科研机构提供从药物发现到原料药和医药中间体的规模化生产的相关产品和技术服务。

成立日期	(6年)
注册资本	300万人民币
员工人数	10-50人
年营业额	￥ 500万-1000万
经营模式	工厂,试剂,定制,服务
主营行业	标准品和对照品,医药中间体,癌症研究,生物活性小分子,诊断试剂